References
- Abraham , J. 2002 . A social science framework for the analysis of health technology regulation: The risks and benefits of innovative pharmaceuticals in a comparative context . Health, Risk & Society , 4 ( 3 ) : 305 – 324 .
- Alaszewski , A. and Brown , P. 2012 . Making health policy: A critical introduction , Cambridge : Polity Press . In Press
- Bissell , P. , May , C. R. and Noyce , P. R. 2004 . From compliance to concordance: Barriers to accomplishing a re-framed model of health care interactions . Social science & medicine , 58 ( 4 ) : 851 – 862 .
- Davis , C. and Abraham , J. 2011 . A comparative analysis of risk management strategies in European Union and United States pharmaceutical regulation . Health, Risk & Society , 13 ( 5 ) : this issue
- Gardner , J. G. and Drew , K. 2011 . The Eltroxin controversy: Risk, and how actors construct their world . Health, Risk & Society , 13 ( 5 ) : this issue
- Harrison , L. 2011 . ‘I don’t know anyone that has two drinks a day’: Young people, alcohol and the government of pleasure . Health, Risk & Society , 13 ( 5 ) : this issue
- Himmelstein , M. 2011 . Over-the-counter cough and cold medicines for children: A comparison of UK and US parents’ parental usage, perception and trust in governmental health organisation . Health, Risk & Society , 13 ( 5 ) : this issue
- Hood , C. 1999 . Explaining risk regulation regimes: Exploring the ‘minimal feasible response’ hypothesis . Health, Risk & Society , 1 ( 2 ) : 151 – 166 .
- Jin , C. 2011 . Framing a global health risk from the bottom-up: User perceptions and practices around antibiotics in four villages in China . Health, Risk & Society , 13 ( 5 ) : this issue
- Lyng , S. 1990 . Edgework: A social psychological analysis of voluntary risk taking . American Journal of Sociology , 95 ( 4 ) : 851 – 886 .
- McGovern , R. and McGovern , W. 2011 . Voluntary risk-taking and heavy-end crack cocaine use: An edgework perspective . Health, Risk & Society , 13 ( 5 ) : this issue
- Moran , M. 2003 . The British regulatory state: High modernism and hyper-innovation , Oxford : Oxford University Press .
- Osimani , B. 2010 . Pharmaceutical risk communication: Sources of uncertainty and legal tools of uncertainty management . Health, Risk & Society , 12 ( 5 ) : 453 – 469 .
- Petersen , A. 1997 . “ Risk, governance and the new public health ” . In Foucault, health and medicine , Edited by: Petersen , A. and Bunton , R. 189 – 204 . London : Routledge .
- Yi-Mak , K. and Harrison , L. 2001 . Globalisation, cultural change and the modern drug epidemics: The case of Hong Kong . Health, Risk & Society , 3 ( 1 ) : 39 – 57 .